[Current pharmacological principles to inhibit platelet function and their clinical implications. Focus on clopidogrel].

@article{Schroer2004CurrentPP,
  title={[Current pharmacological principles to inhibit platelet function and their clinical implications. Focus on clopidogrel].},
  author={Karsten Schroer},
  journal={Medizinische Klinik},
  year={2004},
  volume={99 Suppl 1},
  pages={3-7}
}
Clopidogrel is a further-developed analog of ticlopidine and currently the only therapeutic alternative for long-term prophylaxis and therapy of atherothrombosis. According to the CAPRIE trial, clopidogrel causes significantly less gastrointestinal bleeding than plain aspirin (ASA). There is an increased antiplatelet efficacy by combining clopidogrel with… CONTINUE READING